Pharmaceuticals News and Research

RSS
Jardiance (empagliflozin) tablets now available in U.S. for people with diabetes

Jardiance (empagliflozin) tablets now available in U.S. for people with diabetes

Insight could lead to new and better drugs

Insight could lead to new and better drugs

ZO Skin Health reveals two new ZO Medical formulations to address hyperpigmentation

ZO Skin Health reveals two new ZO Medical formulations to address hyperpigmentation

Ruthigen gets DMC recommendation to begin RUT58-60 Phase 1/2 clinical trial

Ruthigen gets DMC recommendation to begin RUT58-60 Phase 1/2 clinical trial

Viewpoints: Spreading Ebola treatments; Dems can win running on health law

Viewpoints: Spreading Ebola treatments; Dems can win running on health law

Acromegaly and antisense therapy: an interview with Mark Diamond, CEO Antisense Therapeutics

Acromegaly and antisense therapy: an interview with Mark Diamond, CEO Antisense Therapeutics

NEOMED gets $12 million to support academic researchers on drug development

NEOMED gets $12 million to support academic researchers on drug development

Spring Bioscience launches PD-L1 (SP142) rabbit monoclonal immunohistochemistry antibody1

Spring Bioscience launches PD-L1 (SP142) rabbit monoclonal immunohistochemistry antibody1

Emdeon Easy Save: A simplified copay coupon assistance program for retail pharmacies

Emdeon Easy Save: A simplified copay coupon assistance program for retail pharmacies

Cilag GmbH International acquires biopharmaceutical company, Covagen AG

Cilag GmbH International acquires biopharmaceutical company, Covagen AG

Sanofi, Regeneron present alirocumab Phase 3 trial results at ESC Congress 2014

Sanofi, Regeneron present alirocumab Phase 3 trial results at ESC Congress 2014

Aldea Pharmaceuticals announces closure of $24M Series B equity financing

Aldea Pharmaceuticals announces closure of $24M Series B equity financing

Penn Medicine launches CAROT to build novel therapies for retinal and ocular disorders

Penn Medicine launches CAROT to build novel therapies for retinal and ocular disorders

Ohio State, Nationwide Children's Hospital partner with ENTvantage for diagnosing bacterial sinusitis

Ohio State, Nationwide Children's Hospital partner with ENTvantage for diagnosing bacterial sinusitis

Auxilium Pharmaceuticals' CCH drug effective against cellulite in Phase 2a study

Auxilium Pharmaceuticals' CCH drug effective against cellulite in Phase 2a study

NeuroDerm signs definitive investment agreements for $16 million financing round

NeuroDerm signs definitive investment agreements for $16 million financing round

Boehringer Ingelheim announces FDA acceptance of NDA filing for tiotropium and olodaterol FDC

Boehringer Ingelheim announces FDA acceptance of NDA filing for tiotropium and olodaterol FDC

Glenmark announces discovery and initiation of IND enabling studies of innovative bispecific antibody

Glenmark announces discovery and initiation of IND enabling studies of innovative bispecific antibody

KalVista begins Phase I trial of novel plasma kallikrein inhibitor for treatment of DME

KalVista begins Phase I trial of novel plasma kallikrein inhibitor for treatment of DME

New antibodies could pave way for more effective drugs to combat influenza infection

New antibodies could pave way for more effective drugs to combat influenza infection

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.